IO Biotech, Inc. (IOBT)

IO Biotech Statistics

Total Valuation

IO Biotech has a market cap or net worth of $104.09 million. The enterprise value is $84.32 million.

Market Cap	104.09M
Enterprise Value	84.32M

Important Dates

The last earnings date was Thursday, August 14, 2025, after market close.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

IO Biotech has 65.88 million shares outstanding. The number of shares has increased by 6.14% in one year.

Current Share Class	65.88M
Shares Outstanding	65.88M
Shares Change (YoY)	+6.14%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.34%
Owned by Institutions (%)	16.95%
Float	34.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	65.39
P/TBV Ratio	65.38
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.96, with a Debt / Equity ratio of 5.25.

Current Ratio	1.96
Quick Ratio	1.47
Debt / Equity	5.25
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-392.10

Financial Efficiency

Return on equity (ROE) is -212.51% and return on invested capital (ROIC) is -114.42%.

Return on Equity (ROE)	-212.51%
Return on Assets (ROA)	-80.63%
Return on Invested Capital (ROIC)	-114.42%
Return on Capital Employed (ROCE)	-442.29%
Revenue Per Employee	n/a
Profits Per Employee	-$1.30M
Employee Count	80
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, IO Biotech has paid $918,000 in taxes.

Income Tax	918,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	0.44
52-Week Price Change	n/a
50-Day Moving Average	1.73
200-Day Moving Average	1.17
Relative Strength Index (RSI)	44.26
Average Volume (20 Days)	8,602,888

Short Selling Information

The latest short interest is 1.48 million, so 2.25% of the outstanding shares have been sold short.

Short Interest	1.48M
Short Previous Month	851,154
Short % of Shares Out	2.25%
Short % of Float	4.28%
Short Ratio (days to cover)	0.23

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-99.20M
Pretax Income	-87.64M
Net Income	-103.99M
EBITDA	-98.95M
EBIT	-99.20M
Earnings Per Share (EPS)	-$1.58

Balance Sheet

The company has $28.13 million in cash and $8.36 million in debt, giving a net cash position of $19.78 million or $0.30 per share.

Cash & Cash Equivalents	28.13M
Total Debt	8.36M
Net Cash	19.78M
Net Cash Per Share	$0.30
Equity (Book Value)	1.59M
Book Value Per Share	0.02
Working Capital	19.08M

Cash Flow

In the last 12 months, operating cash flow was -$83.33 million and capital expenditures -$75,000, giving a free cash flow of -$83.40 million.

Operating Cash Flow	-83.33M
Capital Expenditures	-75,000
Free Cash Flow	-83.40M
FCF Per Share	-$1.27

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

IO Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.14%
Shareholder Yield	-6.14%
Earnings Yield	-99.90%
FCF Yield	-80.12%

Analyst Forecast

The average price target for IO Biotech is $8.67, which is 448.73% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.67
Price Target Difference	448.73%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1